Detalhe da pesquisa
1.
Major impact of an early bone marrow checkpoint (day 21) for minimal residual disease in flow cytometry in childhood acute lymphoblastic leukemia.
Hematol Oncol
; 35(2): 237-243, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26449287
2.
CD304 is preferentially expressed on a subset of B-lineage acute lymphoblastic leukemia and represents a novel marker for minimal residual disease detection by flow cytometry.
Cytometry A
; 81(1): 17-24, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22052678
3.
Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis.
Haematologica
; 97(7): 1036-41, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22532522
4.
Morphology, cytogenetics, and survival in myelodysplasia with del(20q) or ider(20q): a multicenter study.
Ann Hematol
; 91(2): 203-13, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21744002
5.
The closely related rare and severe acute myeloid leukemias carrying EVI1 or PRDM16 rearrangements share singular biological features.
Haematologica
; 100(3): e114-5, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25740106
6.
Childhood near-tetraploid acute lymphoblastic leukemia: an EGIL study on 36 cases.
Eur J Haematol
; 85(4): 300-8, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20561032
7.
Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia.
Br J Haematol
; 145(5): 624-36, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19388928
8.
Combination of chemotherapy and gemtuzumab ozogamicin in adult Philadelphia positive acute lymphoblastic leukemia patient harboring CD33 expression.
Int J Hematol
; 88(2): 209-211, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18668307
9.
The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement.
Haematologica
; 92(10): 1335-42, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18024371
10.
Administration of mylotarg 4 days after beginning of a chemotherapy including intermediate-dose aracytin and mitoxantrone (MIDAM regimen) produces a high rate of complete hematologic remission in patients with CD33+ primary resistant or relapsed acute myeloid leukemia.
Leuk Res
; 29(9): 1003-7, 2005 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16038726
11.
Four-color flow cytometry bypasses limitations of IG/TCR polymerase chain reaction for minimal residual disease detection in certain subsets of children with acute lymphoblastic leukemia.
Haematologica
; 90(11): 1516-23, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16266899
12.
Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter study.
Cytometry B Clin Cytom
; 88(1): 21-9, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25363877
13.
14q32 Translocations discriminate IgM multiple myeloma from Waldenstrom's macroglobulinemia.
Semin Oncol
; 30(2): 153-5, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12720126
14.
Absence of JAK2-V617F in paroxysmal nocturnal haemoglobinuria-associated thrombosis.
Thromb Haemost
; 102(1): 180-2, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19572087
15.
Acute megakaryoblastic leukaemia: a national clinical and biological study of 53 adult and childhood cases by the Groupe Français d'Hématologie Cellulaire (GFHC).
Leuk Lymphoma
; 44(1): 49-58, 2003 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-12691142
16.
Persistence of CD33 expression at relapse in CD33(+) acute myeloid leukaemia patients after receiving Gemtuzumab in the course of the disease.
Br J Haematol
; 143(5): 744-6, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19036018
17.
Two cases of acute lymphoblastic leukaemia following acute myeloid leukaemia.
Leuk Res
; 32(6): 1001-3, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18093650
18.
Normal levels of peripheral CD19(+) CD5(+) CLL-like cells: toward a defined threshold for CLL follow-up -- a GEIL-GOELAMS study.
Cytometry B Clin Cytom
; 80(6): 346-53, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21976156
19.
Evaluation of a telemedicine system for the transmission of morpho/immunological data aiming at the inclusion of patients in a therapeutic trial.
Int J Telemed Appl
; 2009: 767145, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19190767
20.
A phase II trial of high-dose imatinib mesylate for relapsed or refractory c-kit positive and Bcr-Abl negative acute myeloid leukaemia: the AFR-15 trial.
Leuk Res
; 33(8): 1124-6, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18990444